Clinical Trial

Opzelura Experience Study

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Atopic dermatitis is a common multifactorial skin disease. Topicals are the mainstay of treatment, but adherence to topicals is often abysmal, possibly worsened by the complexity of recommended treatment algorithms. Giving patients a simple, one drug approach may be advantageous.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-17.
Trial Details
NCT Number NCT07661979
Lead Sponsor Wake Forest University Health Sciences
Conditions Atopic Dermatitis
Enrollment 50 participants
Start Date 2026-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-14